BN Business News
Add your company to Business Communicator →

Business · 22/04/2016

FDA Extends Comment Period for Human Cells, Tissues, and Cellular and Tissue-Based Products Guidance Documents

The FDA is extending the comment period for four draft guidance documents to allow more time for public input and submission of new information.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights